文献速递皮肤肿瘤

皮肤癌与黑色素瘤风险评分用于人群筛查的临床价值:TRoPICS研究

Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-12-27

在志愿者皮肤癌筛查门诊中,507名成年人依据既往问卷式风险工具被分为五个风险等级并接受皮肤科医生全身皮肤检查,可疑病变均经活检病理确诊。角质形成细胞癌(KC)检出比例随风险等级升高而增加(从最低等级<1%到最高等级24%,P<0.001),但黑色素瘤在低风险与高风险组检出比例相近。KC风险预测模型可可靠识别高风险人群,黑色素瘤预测工具尚需更大样本验证。

要点

  • KC风险评分可区分社区筛查中的高风险人群,最高风险等级KC检出达24%。
  • BCC与SCC亚型分析均显示检出比例随风险等级上升。
  • 黑色素瘤在低风险与高风险组检出比例相近,其预测工具需扩大样本验证。

核心结论

  • 用于角质形成细胞癌的风险预测模型可在社区皮肤检查前可靠识别有显著皮肤癌负担的个体。
  • 黑色素瘤预测工具需在暴露于更广泛环境风险因素的更大样本中检验。

研究设计与样本

  • 志愿者皮肤癌筛查门诊的前瞻性研究,789名就诊者中507名(64%)同意参与。
  • 采用既往发表的基于问卷的风险工具预测黑色素瘤与角质形成细胞癌,并将参与者分为五个风险等级。
  • 参与者随后由皮肤科医生行全身皮肤检查,所有可疑病变均活检并经组织病理学确诊。

主要发现

  • 角质形成细胞癌检出比例随风险等级升高而增加,从最低等级<1%到最高等级24%(P<0.001)。
  • 亚型分析显示BCC或SCC患病率随风险等级呈类似的比例上升。
  • 黑色素瘤在低风险组与高风险组的检出比例相近。

关键数值与推荐

  • 角质形成细胞癌检出比例:最低风险等级<1%,最高风险等级24%(P<0.001)。

临床怎么用

  • 社区筛查中可先用KC风险评分工具筛选高风险个体,再安排皮肤科检查以优化资源。
  • 不应仅凭现有黑色素瘤风险评分决定是否筛查黑色素瘤,需结合其他评估。

局限性

  • 黑色素瘤病例数少(8例),预测工具需更大样本及更广环境风险暴露人群验证。
  • 研究在志愿者筛查门诊开展,结论外推至一般人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Screening for skin cancer can be cost-effective if focused on high-risk groups. Risk prediction tools have been developed for keratinocyte cancers and melanoma to optimize advice and management. However, few have been validated in a clinical setting over the past few years. OBJECTIVES: To assess the clinical utility of risk assessment tools to identify individuals with prevalent skin cancers in a volunteer-based screening clinic. METHODS: Participants were adults presenting for a skin check at a volunteer-based skin cancer screening facility. We used previously published tools, based on questionnaire responses, to predict melanoma and keratinocyte cancers [KCs; basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)] and classified each participant into one of five risk categories. Participants subsequently underwent a full skin examination by a dermatologist. All suspicious lesions were biopsied, and all cancers were histopathologically confirmed. RESULTS: Of 789 people who presented to the clinic, 507 (64%) consented to the study. Twenty-two BCCs, 19 SCCs and eight melanomas were diagnosed. The proportion of keratinocyte cancers diagnosed increased according to risk category from <1% in the lowest to 24% in the highest risk category (P < 0.001). Subtype analysis revealed similar proportionate increases in BCC or SCC prevalence according to risk category. However, a similar proportion of melanoma cases were detected in the low-risk and high-risk groups. CONCLUSION: The risk prediction model for keratinocyte cancers can reliably identify individuals with a significant skin cancer burden prior to a skin examination in the community setting. The prediction tool for melanoma needs to be tested in a larger sample exposed to a wider range of environmental risk factors.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Shetty A, Janda M, Fry K, et al. Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study. J Eur Acad Dermatol Venereol. 2020. PMID: 33274462. doi:10.1111/jdv.17062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。